43 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18653869 | COMPOSITIONS AND METHODS OF ALLEVIATING RESISTANCE TO CHEMOTHERAPY | GIBBS, TERRA C | 1635 | Final Rejection | May 02, 2024 |
| 18607972 | SYSTEMS AND METHODS RELATED TO DOSIMETRY FOR RADIOEMBOLIZATION, CHEMOEMBOLIZATION, AND DRUG ELUTING EMBOLIZATION PROCEDURES | KIKNADZE, IRAKLI | 2884 | Non-Final OA | Mar 18, 2024 |
| 18424395 | BI-SPECIFIC TARGETED CHIMERIC ANTIGEN RECEPTOR T CELLS | GRABER, JAMES J | 1631 | Final Rejection | Jan 26, 2024 |
| 18488859 | TREATMENT OF CANAVAN DISEASE | BERTOGLIO, VALARIE E | 1632 | Non-Final OA | Oct 17, 2023 |
| 18284413 | CAR T CELL THERAPY AND IFN GAMMA | LEE, YIE CHIA | 1642 | Non-Final OA | Sep 27, 2023 |
| 18279581 | MUC16 PROMOTER CONTAINING VIRUS | ALAM, DANYAL HASSAN | 1672 | Non-Final OA | Aug 30, 2023 |
| 18277367 | TRUNCATED DOMAIN IV EGFR AND USES THEREOF | BELYAVSKYI, MICHAIL A | 1644 | Non-Final OA | Aug 15, 2023 |
| 18277218 | ANTI-DOMAIN IV EGFR ANTIBODIES AND USES THEREOF | DARPOLOR, JOSEPHINE KEBBEH | 1642 | Non-Final OA | Aug 14, 2023 |
| 18361492 | METHODS OF TREATING A CORONAVIRUS INFECTION | DROUIN, STEVE HOANG | 1627 | Non-Final OA | Jul 28, 2023 |
| 18220070 | PREVENTION OR TREATMENT OF WASTING SYNDROME | GROOMS, TIFFANY NICOLE | 1637 | Non-Final OA | Jul 10, 2023 |
| 18265544 | COMPOUNDS AND METHODS TO TREAT CYSTIC FIBROSIS | PRONZATI, GINA | 1633 | Non-Final OA | Jun 06, 2023 |
| 18255503 | PREVENTION AND TREATMENT OF GRAFT-VERSUS-HOST DISEASE (GVHD) | CESARE, JOSEPH DAVID | 1675 | Non-Final OA | Jun 01, 2023 |
| 18038423 | COMPOSITIONS AND USES OF PSCA TARGETED CHIMERIC ANTIGEN RECEPTOR MODIFIED CELLS | FAUST, AMBER KATHLEEN | 1643 | Non-Final OA | May 23, 2023 |
| 18320106 | COMPOSITION AND METHODS FOR 3D CULTURE OF ISLET CELLS | SMITH, ADAM MICHAEL | 1638 | Non-Final OA | May 18, 2023 |
| 18033980 | NUCLEIC ACIDS, PROTEINS, AND VACCINES OF SARS-COV-2 | GILL, RACHEL B | 1671 | Non-Final OA | Apr 26, 2023 |
| 18032201 | HYDROPHOBIC DRUGS IN ORGANIC CORE HIGH DENSITY LIPOPROTEIN (HDL) NANOPARTICLES | AL-AWADI, DANAH J | 1615 | Non-Final OA | Apr 17, 2023 |
| 18032052 | VACCINATION OF HEMATOPOIETIC STEM CELL DONORS WITH CYTOMEGALOVIRUS TRIPLEX COMPOSITION | SALVOZA, M FRANCO G | 1672 | Non-Final OA | Apr 14, 2023 |
| 18026335 | EX VIVO EXPANSION OF REGULATORY T CELLS FOR SUPPRESSION OF GRAFT VERSUS HOST DISEASE | JUEDES, AMY E | 1644 | Non-Final OA | Mar 14, 2023 |
| 18042434 | LAMP DETECTION OF SARS-COV-2 IN SALIVA FOR THE RAPID DIAGNOSIS OF COVID-19 | SWITZER, JULIET CAROLINE | 1682 | Non-Final OA | Feb 21, 2023 |
| 18017982 | TREATMENTS FOR CANCERS HAVING KRAS MUTATIONS | MARTINEZ, TARA L | 1654 | Non-Final OA | Jan 25, 2023 |
| 18017841 | PEPTIDE DESIGN AND GALECTIN-3 INHIBITORS | MACFARLANE, STACEY NEE | 1675 | Non-Final OA | Jan 24, 2023 |
| 18066132 | MULTIVALENT MEDITOPES, MEDITOPE-BINDING ANTIBODIES AND USES THEREOF | DIBRINO, MARIANNE | 1641 | Non-Final OA | Dec 14, 2022 |
| 18073397 | 3 FLAP OKAZAKI FRAGMENTS AND USES THEREOF | VANN-OJUEKAIYE, KENDRA RAYCHELL | 1682 | Non-Final OA | Dec 01, 2022 |
| 17999680 | PHOSPHOROTHIOATE NUCLEIC ACID CONJUGATES INCLUDING DNA EDITING ENZYMES | GOMEZ RODRIGUEZ, JULIO WASHINGTON | 1637 | Non-Final OA | Nov 22, 2022 |
| 17998011 | METHODS FOR ORGANOIDS PRODUCTION | LEPAGE, JONATHAN EVERETT | 1796 | Non-Final OA | Nov 04, 2022 |
| 17976670 | NASAL SWAB | KREMER, MATTHEW | 3791 | Final Rejection | Oct 28, 2022 |
| 17919178 | FLT3-TARGETED CHIMERIC ANTIGEN RECEPTOR MODIFIED CELLS FOR TREATMENT OF FLT3-POSITIVE MALIGNANCIES | REDDIG, PETER J | 1646 | Final Rejection | Oct 14, 2022 |
| 17906467 | MULTIVALENT CHEMOKINE RECEPTOR BINDING COMPLEXES | PATTERSON, SARAH COOPER | 1675 | Non-Final OA | Sep 15, 2022 |
| 17910459 | DUAL-TARGETING CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS COMPRISING IL-13 AND CHLOROTOXIN FOR CANCER TREATMENT | HILL, KEVIN KAI | 1638 | Non-Final OA | Sep 09, 2022 |
| 17870024 | CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING CEA AND ANTI-CEA-IL2 IMMUNOCYTOKINES FOR CANCER THERAPY | PATTERSON, SARAH COOPER | 1675 | Non-Final OA | Jul 21, 2022 |
| 17789930 | METHODS OF MAKING AND USING REGULATORY T CELLS AND EFFECTOR T CELLS HAVING CHIMERIC ANTIGEN RECEPTORS TARGETED TO CD6, CD19, AND/OR AN IL-13R FOR TREATMENT OF AUTOIMMUNE DISORDERS AND CANCERS | BELYAVSKYI, MICHAIL A | 1644 | Non-Final OA | Jun 29, 2022 |
| 17845949 | Chemically Encoded Spatially Addressed Library Screening Platforms | FLINDERS, JEREMY C | 1684 | Final Rejection | Jun 21, 2022 |
| 17843073 | ACCESS NEEDLE SYSTEMS AND METHODS | LI, JOHN DENNY | 3798 | Non-Final OA | Jun 17, 2022 |
| 17774088 | GENERATION OF CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS FROM STEM CELLS AND THERAPEUTIC USES THEREOF | WESTON, ALYSSA G | 1633 | Final Rejection | May 03, 2022 |
| 17767398 | CANCER COMBINATION TREATMENTS USING ANTI-STAT3 NUCLEIC ACID CONJUGATES | STONEBRAKER, ALYSSA RAE | 1642 | Final Rejection | Apr 07, 2022 |
| 17764708 | METAL CHELATING AGENTS AND METHODS OF USING THE SAME | SCHLIENTZ, LEAH H | 1618 | Final Rejection | Mar 29, 2022 |
| 17632869 | DUAL BISPECIFIC ANTIBODY COMPOUNDS AND USES THEREOF | GURLEY, JAMI MICHELLE | 1647 | Non-Final OA | Feb 04, 2022 |
| 17621909 | PDL1 POSITIVE NK CELL CANCER TREATMENT | LU, CHENG | 1642 | Final Rejection | Dec 22, 2021 |
| 17615695 | APTAMERS AGAINST TRANSFERRIN RECEPTOR | SHIN, DANA H | 1635 | Final Rejection | Dec 01, 2021 |
| 17520402 | CHIMERIC ANTIGEN RECEPTORS CONTAINING A CHLOROTOXIN DOMAIN | HINES, JANA A | 1645 | Non-Final OA | Nov 05, 2021 |
| 17184987 | Surgical Gauze | ARBLE, JESSICA R | 3781 | Final Rejection | Feb 25, 2021 |
| 17269229 | OLIGONUCLEOTIDE INHIBITORS OF NUCLEAR FACTOR KAPPA-LIGHT-CHAIN-ENHANCER OF ACTIVATED B CELLS AND THE USES THEREOF | ZAHORIK, AMANDA MARY | 1636 | Non-Final OA | Feb 17, 2021 |
| 16604151 | P38 GAMMA INHIBITORS AND METHOD OF USE THEREOF | LEE, ANDREW P | 1691 | Non-Final OA | Oct 09, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial